TrialMolecular therapy : the journal of the American Society of Gene Therapy2010

Phase II clinical trial of intratumoral application of TG1042 (adenovirus-interferon-gamma) in patients with advanced cutaneous T-cell lymphomas and multilesional cutaneous B-cell lymphomas.

Reinhard Dummer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.